Latest Announcements

Sanofi India Limited has declared an Interim Dividend of Rs. 75 per equity share for the financial year 2026, with a record date of November 5, 2026, and the dividend to be paid within stipulated timelines. The company has also announced its financial results for the quarter ended September 30, 2026, reporting domestic net sales growth of 2% and total net sales growth of 4% compared to the third quarter of 2025.

Strides Pharma Science Limited has announced its Q2 and H1FY27 earnings, with revenue growing 17% YoY to ₹14,297m and ₹26,951m respectively, driven by Ex-US Markets. EBITDA grew 8% YoY to ₹2,509m and ₹4,807m respectively, despite higher raw material, freight and operating costs. Net Debt increased by ₹2,114m during H1 due to an elongated cash-to-cash cycle and higher inventory holding.

Strides Pharma Science Ltd reported Q2FY27 revenue of ₹14,297m, up 17% YoY, driven by Ex-US Markets growth of 31% YoY. EBITDA grew to ₹2,509m, crossing ₹2,500m for the first time, despite higher input material and freight costs.

Sanofi India Limited has announced its financial results for the quarter ended September 30, 2026, with a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company has also declared an interim dividend of Rs. 75 per equity share and fixed November 5, 2026, as the record date for the payment of the dividend.

Capital Small Finance Bank Ltd reported unaudited financial results for Q2 FY27, with Gross Advances growing 23.4% Y-o-Y to ₹9,755 crore, Total Deposits rising 16.2% Y-o-Y to ₹10,831 crore, and Profit After Tax increasing 30.7% Y-o-Y to ₹45.61 crore.

Sanofi India Limited has announced its Q3 2026 financial results, reporting a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company's Insulin portfolio delivered a 9% growth in Q3'26, cementing its leadership in the Diabetes Injectable segment with a 55% market share.

Capital Small Finance Bank Ltd has released its unaudited financial results for the period ended September 30, 2026, showing a 7.5% QoQ and 23.4% YoY growth in loan book, 2.2% QoQ and 16.2% YoY growth in deposits, and a 31% YoY growth in profit after tax.

Capital Small Finance Bank Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with Gross Advances increasing to ₹9,755 crore, total Deposits rising to ₹10,831 crore, and Profit After Tax standing at ₹45.61 crore.

Capital Small Finance Bank Limited has released its investor presentation for the period ended September 30, 2026, highlighting its unaudited financial results, including a 23.4% YoY growth in loan book, 16.2% YoY growth in deposits, and a 31% YoY growth in profitability.

Steamhouse India Limited has submitted its Investor Presentation for Q2 & H1 FY27, highlighting a strong year-on-year performance despite seasonal moderation, with a 12.06% year-on-year growth in steam supply volumes and a focus on sustaining growth momentum.

Strides Pharma Science Limited has announced its Q2FY27 financial results, with revenue growing 17% YoY to ₹14,297m, driven by Ex-US Markets, and EBITDA up 8% YoY to ₹2,509m, crossing ₹2,500m in a quarter for the first time.

Sanofi India Ltd has announced its Q3 2026 financial results, reporting a 2% growth in domestic net sales and a 4% growth in total net sales. The company has also declared an interim dividend of Rs. 75 per equity share.

Kajaria Ceramics Limited reported 10% year-to-year volume growth in Q2 FY27, driven by better demand and market share gains. Consolidated revenue grew 24% year-to-year to INR1,468 crores, with EBITDA margin at 19.5%. The company's capacity expansion plans remain on track, and it expects to sustain healthy growth and strengthen its market position.

Kajaria Ceramics Ltd reported 10% year-to-year volume growth in Q2 FY27, driven by better demand and market share gain. Consolidated revenue grew 24% YoY to INR1,468 crores, with EBITDA margin at 19.5%. The company's capacity expansion plans remain on track.

Afcons Infrastructure Limited has secured two significant engineering, procurement and construction (EPC) contracts in Uttar Pradesh with a combined value of nearly ₹3,469 crore. The projects comprise the development of the Jewar Link Expressway and a key underground section of the Lucknow Metro Phase-1B.

Sanofi India Ltd has announced its financial results for the quarter ended September 30, 2026, with domestic net sales growth of 2% and total net sales growth of 4% compared to the third quarter of 2025. The company has also declared an interim dividend of Rs. 75 per equity share for the financial year 2026.

Afcons Infrastructure Ltd has secured two significant engineering, procurement and construction (EPC) contracts in Uttar Pradesh with a combined value of nearly ₹3,469 crore. The projects comprise the development of the Jewar Link Expressway and a key underground section of the Lucknow Metro Phase-1B.

Ram Ratna Wires Ltd has received a positive credit rating from CARE Ratings Limited, with a revised outlook from stable to positive, due to its experienced promoters, prominent position in the copper winding wires industry, and healthy growth in its scale of operations.

Sanofi India Ltd declared an interim dividend of Rs. 75 per equity share for the financial year 2026, with a record date of November 5, 2026. The company also announced its unaudited financial results for the quarter and nine months ended September 30, 2026, with a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025.

Tata Consumer Products Limited has announced its Q2 FY27 results, with revenue up 14%, EBITDA up 18%, and net profit at INR470 crores, growing 16%. The company's growth businesses, including Sampann and Ready-to-Drink, have shown strong performance, with Sampann up 57% and Ready-to-Drink strongly back on the growth trajectory with 47% growth.